GLICLAZIDE (GLIZ) MR 60MG TABS 30’S

Gliclazide (GLIZ) MR 60mg Tablets (30’s)

Gliclazide MR 60mg is a modified-release oral antidiabetic medication belonging to the sulfonylurea class. It is prescribed for managing blood glucose levels in patients with type 2 diabetes mellitus.

Key Features:

• Stimulates pancreatic beta cells to release insulin, helping reduce blood sugar.

• Modified-release formulation ensures a steady release, providing prolonged blood glucose control.

• Once-daily dosing enhances patient compliance.

• Effective as monotherapy or in combination with other antidiabetic drugs.

• Helps reduce complications related to poor blood sugar control.

Indications:

• Management of type 2 diabetes mellitus in adults when diet and exercise alone do not provide adequate glycemic control.

• Can be used as monotherapy or combined with other agents including metformin or insulin.

Dosage & Administration:

• Usually taken once daily with breakfast or the first main meal.

• Dosage individualized based on patient response and risk of hypoglycemia.

• Regular monitoring of blood glucose is recommended.

Precautions:

• Not suitable for type 1 diabetes or diabetic ketoacidosis.

• Caution advised in patients with liver or kidney impairment.

• Educate patients about hypoglycemia symptoms.

• Review all medications to avoid potential drug interactions.

Possible Side Effects:

• Hypoglycemia (low blood sugar)

• Weight gain

• Gastrointestinal discomfort such as nausea or indigestion

• Rare allergic reactions

Storage:

• Store below 30°C in a dry place.

• Keep out of reach of children.